Top-News
Werbung
Attraktive Knock-Outs auf Merck & Co Inc
Typ Hebel Bid / Ask WKN
Call
4,9 1,49 € / 1,53 €
SF8X7M
Typ Hebel Bid / Ask WKN
Put
5,0 1,48 € / 1,52 €
SX0RAW
Den Basisprospekt sowie endgültige Bedingungen und Basisinformationsblätter erhalten Sie bei Klick auf das Dokument-Icon. Beachten Sie auch die weiteren Hinweise zu dieser Werbung. Der Emittent ist berechtigt, Wertpapiere mit open end-Laufzeit zu kündigen.
Alle Knock-Outs auf Merck & Co Inc
Pharmazeutika USA

Merck & Co Inc Aktie

Aktie
WKN:  A0YD8Q ISIN:  US58933Y1055 US-Symbol:  MRK
74,40 €
-0,70 €
-0,93%
14:30:56 Uhr
Depot/Watchlist
Aktienanzahl *
2,53 Mrd.
Marktkapitalisierung *
190,26 Mrd. €
Streubesitz
19,39%
Index-Zugehörigkeit
Dow Jones Industrial Average
IR-Website
zur Website
*Stand: 05.03.2025
Weiter abwärts? Short handeln - Jetzt mit Hebel 7,24: MJ97T7
Werbung

Merck & Co Inc News

04.04.25 - PR Newswire
Merck & Co (MRK) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
Merck & Co (MRK) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit PR Newswire
04.04.25 - PR Newswire
Class Action Filed Against Merck & Co., Inc. (MRK) - April 14, 2025 Deadline to Join - Contact Levi & Korsinsky
Class Action Filed Against Merck & Co., Inc. (MRK) - April 14, 2025 Deadline to Join - Contact Levi & Korsinsky PR Newswire
03.04.25 - PR Newswire
Class Action Filed Against Merck & Co., Inc. (MRK) Seeking Recovery for Investors - Contact The Gross Law Firm
Class Action Filed Against Merck & Co., Inc. (MRK) Seeking Recovery for Investors - Contact The Gross Law Firm PR Newswire
02.04.25 - ARIVA.DE Redaktion
0,11 Prozent Minus: Dow Jones tendiert leichter (41.946 Pkt.)
Die Aktie von Nvidia ist aktuell der größte Verlierer im Dow Jones-​Index. Das Kursbarometer sinkt leicht um 0,11 Prozent.
02.04.25 - PR Newswire
MRK Deadline: MRK Purchasers with Losses in Excess of $100K Have Opportunity to Lead Merck & Co., Inc. Securities Fraud Lawsuit
MRK Deadline: MRK Purchasers with Losses in Excess of $100K Have Opportunity to Lead Merck & Co., Inc. Securities Fraud Lawsuit PR Newswire
02.04.25 - PR Newswire
Merck & Co (MRK) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
Merck & Co (MRK) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit PR Newswire
02.04.25 - PR Newswire
MRK Investors Have Final Opportunity to Lead Merck & Co., Inc. Securities Fraud Lawsuit with the Schall Law Firm
MRK Investors Have Final Opportunity to Lead Merck & Co., Inc. Securities Fraud Lawsuit with the Schall Law Firm PR Newswire
01.04.25 - PR Newswire
Class Action Filed Against Merck & Co., Inc. (MRK) Seeking Recovery for Investors - Contact Levi & Korsinsky
Class Action Filed Against Merck & Co., Inc. (MRK) Seeking Recovery for Investors - Contact Levi & Korsinsky PR Newswire
31.03.25 - PR Newswire
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Merck & Co., Inc. of Class Action Lawsuit and Upcoming Deadlines - MRK
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Merck & Co., Inc. of Class Action Lawsuit and Upcoming Deadlines - MRK PR Newswire
31.03.25 - PR Newswire
Lost Money on Merck & Co., Inc.(MRK)? Join Class Action Suit Seeking Recovery - Contact The Gross Law Firm
Lost Money on Merck & Co., Inc.(MRK)? Join Class Action Suit Seeking Recovery - Contact The Gross Law Firm PR Newswire
28.03.25 - PR Newswire
MRK Purchasers Have Opportunity to Lead Merck & Co., Inc. Securities Fraud Lawsuit
MRK Purchasers Have Opportunity to Lead Merck & Co., Inc. Securities Fraud Lawsuit PR Newswire
28.03.25 - PR Newswire
Lost Money on Merck & Co., Inc.(MRK)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky
Lost Money on Merck & Co., Inc.(MRK)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky PR Newswire
27.03.25 - PR Newswire
Merck & Co (MRK) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
Merck & Co (MRK) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit PR Newswire
27.03.25 - dpa-AFX
ROUNDUP: Ab­schrei­bungen belasten Formycon - Will nachhaltig profitabel werden
Hohe Ab­schrei­bungen haben dem Biotechnologie-​Unternehmen Formycon im vergangenen Jahr erwartungsgemäß rote Zahlen eingebrockt. Auch 2025 dürfte noch einmal ...
27.03.25 - PR Newswire
Class Action Filed Against Merck & Co., Inc. (MRK) - April 14, 2025 Deadline to Join - Contact The Gross Law Firm
Class Action Filed Against Merck & Co., Inc. (MRK) - April 14, 2025 Deadline to Join - Contact The Gross Law Firm PR Newswire
25.03.25 - PR Newswire
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Merck & Co., Inc. of Class Action Lawsuit and Upcoming Deadlines - MRK
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Merck & Co., Inc. of Class Action Lawsuit and Upcoming Deadlines - MRK PR Newswire
25.03.25 - PR Newswire
MRK Investors Have Final Opportunity to Lead Merck & Co., Inc. Securities Fraud Lawsuit with the Schall Law Firm
MRK Investors Have Final Opportunity to Lead Merck & Co., Inc. Securities Fraud Lawsuit with the Schall Law Firm PR Newswire
24.03.25 - PR Newswire
MRK LAWSUIT ALERT: The Gross Law Firm Notifies Merck & Co., Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
MRK LAWSUIT ALERT: The Gross Law Firm Notifies Merck & Co., Inc. Investors of a Class Action Lawsuit and Upcoming Deadline PR Newswire
22.03.25 - PR Newswire
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Merck & Co.
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Merck & Co. PR Newswire
21.03.25 - PR Newswire
Merck & Co (MRK) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
Merck & Co (MRK) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit PR Newswire

Newssuche

Videos

newspaper
30.04.25 +5,62%
Technical Trading: Cotton Long Chance
Cotton Long Typ: Turbo Open End WKN: VP6N8D Hebel: 3,80 Laufzeit: OpenEnd Einstieg: Market ... Mehr »